1590-25-6

Basic information

• Product Name: 2-Acetyl-6-bromonaphthalene
• Synonyms: 1-(6-Bromonaphthalen-2-yl)ethanone;(6-bromo-2-naphthalenyl)ethanone;6-BROMO-2-ACETONAPHTHONE
• CAS NO: 1590-25-6
• Molecular Formula: C₁₂H₉BrO
• Molecular Weight: 249.11
• Mol File: 1590-25-6.mol
• Article Data: 26

Chemical Properties

• Melting Point: 96 °C
• Boiling Point: 357.1±15.0 °C(Predicted)
• Appearance: /
• Density: 1.454±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-Acetyl-6-bromonaphthalene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Acetyl-6-bromonaphthalene(1590-25-6)
• EPA Substance Registry System: 2-Acetyl-6-bromonaphthalene(1590-25-6)

Safety Data

• Hazardous Substances Data: 1590-25-6(Hazardous Substances Data)

Usage

General Description

2-Acetyl-6-bromonaphthalene is a chemical compound that belongs to the class of naphthalene derivatives. It is also known by other names such as 6-Bromo-2-acetylnaphthalene. 2-Acetyl-6-bromonaphthalene is primarily used in the field of organic synthesis and chemical research as a building block for the synthesis of various other compounds. It is known for its high reactivity and ability to undergo various chemical reactions, making it a useful intermediate in the production of pharmaceuticals, agrochemicals, and other fine chemicals. Additionally, it is important to handle this compound with caution due to its potential health hazards and the need for proper safety measures during its handling and storage.

Upstream product

• 100751-63-1 (6-bromo-2-naphthy)methanol 
• 170737-46-9 6-bromo-naphthalene-2-carboxaldehyde 
• 33626-98-1 methyl 6-bromo-2-naphthoate 
• 72775-31-6 1-(2-<6-Brom>naphthyl)ethanol 
• 861880-64-0 6-bromo-N-methoxy-N-methyl-2-naphthamide 
• 676-58-4 methylmagnesium chloride 
• 111-34-2 -butyl vinyl ether 
• 151600-02-1 6-bromo-2-naphthalenyl trifluoromethanesulfonate 
• 15231-91-1 6-bromo-naphthalen-2-ol 
• 5773-80-8 6-bromo-2-naphthoic acid 
• 87700-60-5 6-bromonaphthalene-2-carbonyl chloride 
• 75-16-1 methylmagnesium bromide 
• 201230-82-2 carbon monoxide 
• 594-27-4 tetramethylstannane 

Downstream Products

• 1303533-77-8 C₂₅H₂₂BrN₃O₂ 
• 1242087-97-3 C₄₁H₄₂N₆O₄ 
• 1303533-78-9 C₄₁H₄₂N₆O₄ 
• 1185251-08-4 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid 
• 1313516-26-5 (S)-3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid 
• 1313516-28-7 (S)-methyl 3-(N-(6-acetylnaphthalen-2-yl)-2-nitrophenylsulfonamido)-2-(tritylamino)propanoate 
• 7470-88-4 1-(6-aminonaphthalen-2-yl)ethanone 
• 68520-00-3 1-(6-(dimethylamino)naphthalen-2-yl)ethan-1-one 
• 1318898-75-7 methyl ((1S)-2-methyl-1-{[(2S,3aS,6aS)-2-{5-[6-(2-{(2S,4S)-4-methyl-1-[(2R)-2-phenyl-2-(1-pyrrolidinyl)acetyl]-2-pyrrolidinyl}-1H-imidazol-4-yl)-2-naphthalenyl]-1H-benzimidazol-2-yl}hexahydrocyclopenta[b]pyrrol-1(2H)-yl]carbonyl}propyl)carbamate 
• 1318898-60-0 methyl {(1S)-1-[((2S,4S)-2-{5-[6-(2-{(2S,4S)-1-[(2R)-2-(dimethylamino)-2-phenylacetyl]-4-methyl-2-pyrrolidinyl}-1H-imidazol-4-yl)-2-naphthalenyl]-1H-benzimidazol-2-yl}-4-methyl-1-pyrrolidinyl)carbonyl]-2-methylpropyl}carbamate 
• 1318898-49-5 1,1-dimethylethyl (2S,4S)-2-{4-[6-(3,4-diaminophenyl)-2-naphthalenyl]-1H-imidazol-2-yl}-4-methyl-1-pyrrolidinecarboxylate 
• 1315483-08-9 C₁₉H₁₃BrO₃ 
• 5773-80-8 6-bromo-2-naphthoic acid 
• 50637-82-6 (3-Brom-phenyl)-(6-brom-2-naphthacyl)-sulfid 

Relevant articles and documents

Quantitative Design of Bright Fluorophores and AIEgens by the Accurate Prediction of Twisted Intramolecular Charge Transfer (TICT)

Inhibition of TICT can significantly increase the brightness of fluorescent materials. Accurate prediction of TICT is thus critical for the quantitative design of high-performance fluorophores and AIEgens. TICT of 14 types of popular organic fluorophores

NOVEL BENZIMIDAZOLE DERIVATIVES

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

N - heterocyclic compound, intermediate, preparation method, pharmaceutical composition and application (by machine translation)

The invention discloses a N - heterocyclic compound, intermediate, preparation method, pharmaceutical composition and application. The invention of SHP2 N - heterocyclic compound to have high selectivity, can effectively inhibit the cell in the SHP2 downstream signal path ERK phosphorylation level, to tumor cells has very good inhibition activity, it has broad drug development prospects; its preparation method is simple, mild reaction conditions, high yield and purity, after treatment is simple, environmental protection, and is favorable for industrial production. (by machine translation)